BIO campaign gathers pharma partners to lobby Congress against superbugs
31 Aug 2019 //
FIERCE PHARMA
Key priority is to drive further growth in chronic portfolio: Cipla
12 Aug 2019 //
PHARMABIZ
Once picked as a $500M winner, bankrupt Achaogen auctions off its antibiotic
07 Jun 2019 //
ENDPTS
Achaogen cuts costs again and puts up ‘for sale’ sign
07 Nov 2018 //
FIERCE BIOTECH
Two Genentech vets reunite at I-O to help steer its $33M drive to the clinic
19 Sep 2018 //
ENDPTS
Tetraphase plots Q4 launch for 1st antibiotic after OK for eravacycline
28 Aug 2018 //
ENDPTS
CMS Grants New Technology Add-on Payment to ZEMDRI™ (plazomicin)
03 Aug 2018 //
YAHOO FINANCE
Antibiotics R&D takes another hit as Achaogen slashes research ops
26 Jul 2018 //
ENDPTS
Achaogen wins FDA approval for new antibiotic Zemdri
27 Jun 2018 //
FIERCE PHARMA
Achaogen slides after ‘yes and no’ adcomm verdict on plazomicin
04 May 2018 //
FIERCE BIOTECH
AKAO Slumps On FDA Panel Vote, ESPR Awaits Data In May, STAA Shines
02 May 2018 //
RTTNEWS
Plazomicin sulfate Injection Meeting of the AMDAC
30 Apr 2018 //
BUSINESSWIRE